![Frontiers | Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings | Neurology Frontiers | Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings | Neurology](https://www.frontiersin.org/files/Articles/423607/fneur-10-00253-HTML/image_m/fneur-10-00253-g001.jpg)
Frontiers | Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings | Neurology
![Figure 3 from Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis | Semantic Scholar Figure 3 from Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/28be02dd461bb8b1373f1d48218ec4970fda2074/7-Figure3-1.png)
Figure 3 from Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis | Semantic Scholar
![Proposed mechanism of MS pathogenesis. MΦ, macrophage; EC, Endothelial... | Download Scientific Diagram Proposed mechanism of MS pathogenesis. MΦ, macrophage; EC, Endothelial... | Download Scientific Diagram](https://www.researchgate.net/profile/Mouzaki-Athanasia/publication/7583209/figure/fig1/AS:601672392921108@1520461285602/Fig-1-Proposed-mechanism-of-MS-pathogenesis-MPH-macrophage-EC-Endothelial-Cell-T.png)
Proposed mechanism of MS pathogenesis. MΦ, macrophage; EC, Endothelial... | Download Scientific Diagram
![Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies? - AH Nuyts, WP Lee, R Bashir-Dar, ZN Berneman, N Cools, 2013 Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies? - AH Nuyts, WP Lee, R Bashir-Dar, ZN Berneman, N Cools, 2013](https://journals.sagepub.com/na101/home/literatum/publisher/sage/journals/content/msja/2013/msja_19_8/1352458512473189/20170110/images/medium/10.1177_1352458512473189-fig1.gif)
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies? - AH Nuyts, WP Lee, R Bashir-Dar, ZN Berneman, N Cools, 2013
![Liveblog vrijdag: MS Mode betaalt voorlopig niet meer, Only for Men komt met klein deel over de brug - RetailTrends Liveblog vrijdag: MS Mode betaalt voorlopig niet meer, Only for Men komt met klein deel over de brug - RetailTrends](https://media.prdn.nl/retailtrends/files/MS%20Mode%20opening%206%282%29.jpg?w=850)
Liveblog vrijdag: MS Mode betaalt voorlopig niet meer, Only for Men komt met klein deel over de brug - RetailTrends
![Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries - Multiple Sclerosis - NCBI Bookshelf Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries - Multiple Sclerosis - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-multiple-lrg.png)